European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading

MT Newswires Live01-16

European equities traded in the US as American depositary receipts were little changed late Thursday morning, edging 0.02% higher to 1,753.96 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and internet browser company Opera (OPRA), which rose 4.6% and 3.2%, respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and telecommunications company Ericsson (ERIC), which were up 1.7% and 1%, respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and medical device maker EDAP TMS (EDAP), which fell 3.8% and 3.7%, respectively. They were followed by oil and gas company Eni (E) and biopharmaceutical company Grifols (GRFS), which were down 2.5% and 1.7%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and lender HSBC (HSBC), which advanced 5.2% and 1.2%, respectively. They were followed by telecommunications operator Vodafone Group (VOD) and biopharmaceutical company Akari Therapeutics (AKTX), which increased 1% each.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and alcoholic beverage company Diageo (DEO), which dropped 7.4% and 2.5%, respectively. They were followed by pharmaceutical companies AstraZeneca (AZN) and GSK (GSK), which lost 2.2% and 2.1%, respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment